WebAug 15, 2013 · Aberrant SREBP activity has been linked to metabolic disease states, such as obesity, fatty liver, insulin resistance, hyperlipidemia, and atherosclerosis. Thus, inhibition of SREBP activation is a potential therapeutic approach to treating metabolic disorders. This review focuses on direct or indirect small-molecule inhibitors of SREBP activation. WebOct 18, 2024 · Secreted TAILS levels were significantly increased by all tested stressors, and co-treatment with nelfinavir, an S2P inhibitor that prevents cleavage of TAILS from CREB3L2 (McCurdy et al., 2024), abolished the effect, albeit at varying degrees for each stressor (Figure 2 H). Given the effect size of HNE in this assay and the marked spike of ...
Aspirin metabolite sodium salicylate selectively inhibits ...
WebMay 1, 2024 · 232, 247 Nelfinavir, an HIV protease inhibitor, and 1,10-phenanthroline are S2P inhibitors that similarly prevent the release of nSREBP. 248−250 Like the other compounds targeting the SREBP ... WebApr 15, 2011 · Abstract. We previously reported that nelfinavir-induced apoptosis in liposarcoma is a direct result of regulated intramembrane proteolysis (RIP) inhibition mediated through inhibition of site-2 protease (S2P) activity. We now report similar effects in hormone-resistant prostate cancer (HR-PC) cells. Nelfinavir-mediated RIP inhibition leads … small shredding machine
Molecular Mechanism of the ATF6α/S1P/S2P Signaling Pathway …
WebMost recently, studies have proved the therapeutic potential of SHP2 inhibitor in overcoming drug resistance of kinase inhibitors and programmed cell death-1 (PD-1) blockade. … WebAbstract. Nelfinavir induces apoptosis in liposarcoma by inhibiting site-2 protease (S2P) activity, which leads to suppression of regulated intramembrane proteolysis. We … WebJan 9, 2024 · Imatinib is a platelet-derived growth factor receptor (PDGFR) inhibitor with very low water solubility. Previous studies in atherosclerosis have shown that S2P peptide … small showroom ideas